What amount sold does Thrive Bioscience, Inc. report in Form D filings?

The latest linked filings report $14.4M sold across 4 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Thrive Bioscience, Inc.'s most recent SEC filing?

Thrive Bioscience, Inc.'s most recent Form D filing was on 2017-08-28.

How many investors does Thrive Bioscience, Inc. have?

The most recent Form D filing lists 21 investor(s).

What type of securities does Thrive Bioscience, Inc. offer?

Thrive Bioscience, Inc.'s SEC Form D filings indicate debt offerings.

Thrive Bioscience, Inc.

CIK: 0001642601·Biotechnology·Wakefield, MA·Corporation·Founded 2014

Reported Sold

$14,384,474

Total Filings

Identified Offerings

Last Filed

Aug 28, 2017

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Aug 28, 2017Form D — New notice

Reported sold: $1,801,885 · Target: $2,500,000

Rule 506(b)·21 investors

Mar 7, 2017Form D — New notice

Reported sold: $7,150,000 · Target: $10,000,000

Rule 506(b)·36 investors

Dec 11, 2015Form D — New notice

Reported sold: $2,175,000 · Target: $2,175,000

Rule 506(b)·20 investors

May 15, 2015Form D — New notice

Reported sold: $3,257,589 · Target: $4,000,000

Rule 506(b)·24 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 4 identified offerings

$14,384,474

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Thomas Forest Farb

Related Person

Appears on 2 filings

Alan Philippe Blanchard

Related Person

Appears on 2 filings

Guy Broadbent

Related Person

Appears on 2 filings

Brock Reeve

Related Person

Appears on 2 filings

Michael Finney

Related Person

Appears on 2 filings

Alan Philippe Blanchard

Related Person

Appears on 2 filings

Thomas Forest Farb

Related Person

Appears on 2 filings

Brock Reeve

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Aug 28, 2017	New	$2,500,000	$1,801,885	21
Mar 7, 2017	New	$10,000,000	$7,150,000	36
Dec 11, 2015	New	$2,175,000	$2,175,000	20
May 15, 2015	New	$4,000,000	$3,257,589	24

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

OrthoIQ, Inc.

Biotechnology

Offering target: $1,400,000

Filed Oct 23, 2026